GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TNXP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Tonix Pharmaceuticals stock price ended at $0.157 on Thursday, after losing 1.51%.
(Updated on Apr 18, 2024)

Sell candidate since Mar 21, 2024 Loss -54.43% PDF

The Tonix Pharmaceuticals stock price fell by -1.51% on the last day (Thursday, 18th Apr 2024) from $0.159 to $0.157. During the last trading day the stock fluctuated 9.13% from a day low at $0.150 to a day high of $0.164. The price has fallen in 6 of the last 10 days and is down by -16% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -604 thousand shares and in total, 1 million shares were bought and sold for approximately $221.48 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.138 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -33.88% during the next 3 months and, with a 90% probability hold a price between $0.0914 and $0.203 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TNXP Signals & Forecast

There are mixed signals in the stock today. The Tonix Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.160 and $0.275. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 7.61%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Tonix Pharmaceuticals stock

Tonix Pharmaceuticals finds support from accumulated volume at $0.150 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0137 between high and low, or 9.13%. For the last week the stock has had daily average volatility of 14.04%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TNXP) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Tonix Pharmaceuticals Holding Corp. to open at $0.157, and during the day (based on 14 day Average True Range), to move between $0.131 and $0.183, which gives a possible trading interval of +/-$0.0255 (+/-16.27%) up or down from last closing price. If Tonix Pharmaceuticals Holding Corp. takes out the full calculated possible swing range there will be an estimated 32.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.150 (4.52%) than the resistance at $0.173 (10.45%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Tonix Pharmaceuticals Holding Corp. stock A Buy?

Tonix Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.301 Sell Candidate Unchanged

Predicted Opening Price for Tonix Pharmaceuticals Holding Corp. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$0.157 ( 0.0212%) $0.157

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TNXP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.171 8.70 %
R2 0.165 5.37 %
R1 0.162 3.31 %
Current price: 0.157
Support S1 0.152 -3.35 %
S2 0.149 -5.41 %
S3 0.143 -8.75 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.190 20.96 %
R2 0.186 18.47 %
R1 0.173 10.45 %
Current price 0.157
Support S1 0.150 -4.52%
S2 0.146 -7.07%
S3 0 .

FAQ

What is the symbol for Tonix Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Tonix Pharmaceuticals is TNXP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Tonix Pharmaceuticals Stock?
Tonix Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Tonix Pharmaceuticals Stock?
Tonix Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tonix Pharmaceuticals Stock.

What's the current price of Tonix Pharmaceuticals Stock?
As of the end of day on the 2024-04-18, the price of an Tonix Pharmaceuticals (TNXP) share was $0.157.

What is the 52-week high and low for Tonix Pharmaceuticals Stock?
The 52-week high for Tonix Pharmaceuticals Stock is $2.24 and the 52-week low is $0.120.

What is the market capitalization of Tonix Pharmaceuticals Stock?
As of the 2024-04-18, the market capitalization of Tonix Pharmaceuticals is 13.265M.

When is the next earnings date for Tonix Pharmaceuticals?
The upcoming earnings date for Tonix Pharmaceuticals is May 13, 2024.
Click to get the best stock tips daily for free!

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, auto... TNXP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT